These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 32293487)

  • 1. DCE-MRI of locally-advanced carcinoma of the uterine cervix: Tofts analysis versus non-model-based analyses.
    Lund KV; Simonsen TG; Kristensen GB; Rofstad EK
    Radiat Oncol; 2020 Apr; 15(1):79. PubMed ID: 32293487
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetic analysis of DCE-MRI data of locally advanced cervical carcinoma with the Brix model.
    Lund KV; Simonsen TG; Kristensen GB; Rofstad EK
    Acta Oncol; 2019 Jun; 58(6):828-837. PubMed ID: 30810443
    [No Abstract]   [Full Text] [Related]  

  • 3. Pharmacokinetic parameters derived from dynamic contrast enhanced MRI of cervical cancers predict chemoradiotherapy outcome.
    Andersen EK; Hole KH; Lund KV; Sundfør K; Kristensen GB; Lyng H; Malinen E
    Radiother Oncol; 2013 Apr; 107(1):117-22. PubMed ID: 23333024
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Voxelwise comparison of perfusion parameters estimated using dynamic contrast enhanced (DCE) computed tomography and DCE-magnetic resonance imaging in locally advanced cervical cancer.
    Kallehauge J; Nielsen T; Haack S; Peters DA; Mohamed S; Fokdal L; Lindegaard JC; Hansen DC; Rasmussen F; Tanderup K; Pedersen EM
    Acta Oncol; 2013 Oct; 52(7):1360-8. PubMed ID: 24003852
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The prognostic value of dynamic contrast-enhanced MRI contrast agent transfer constant K
    Dickie BR; Rose CJ; Kershaw LE; Withey SB; Carrington BM; Davidson SE; Hutchison G; West CML
    Br J Cancer; 2017 May; 116(11):1436-1443. PubMed ID: 28449009
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DCE-MRI-Derived Measures of Tumor Hypoxia and Interstitial Fluid Pressure Predict Outcomes in Cervical Carcinoma.
    Simonsen TG; Lund KV; Hompland T; Kristensen GB; Rofstad EK
    Int J Radiat Oncol Biol Phys; 2018 Nov; 102(4):1193-1201. PubMed ID: 29859790
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pretreatment late-phase DCE-MRI predicts outcome in locally advanced cervix cancer.
    Lund KV; Simonsen TG; Kristensen GB; Rofstad EK
    Acta Oncol; 2017 May; 56(5):675-681. PubMed ID: 28447564
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Short-term pretreatment DCE-MRI in prediction of outcome in locally advanced cervical cancer.
    Lund KV; Simonsen TG; Hompland T; Kristensen GB; Rofstad EK
    Radiother Oncol; 2015 Jun; 115(3):379-85. PubMed ID: 25998804
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Added-value of dynamic contrast-enhanced MRI on prediction of tumor recurrence in locally advanced cervical cancer treated with chemoradiotherapy.
    Zhang Q; Guo J; Ouyang H; Chen S; Zhao X; Yu X
    Eur Radiol; 2022 Apr; 32(4):2529-2539. PubMed ID: 34647177
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preclinical evaluation of Gd-DTPA and gadomelitol as contrast agents in DCE-MRI of cervical carcinoma interstitial fluid pressure.
    Hompland T; Ellingsen C; Rofstad EK
    BMC Cancer; 2012 Nov; 12():544. PubMed ID: 23173554
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dynamic contrast-enhanced MRI of cervical cancers: temporal percentile screening of contrast enhancement identifies parameters for prediction of chemoradioresistance.
    Andersen EK; Hole KH; Lund KV; Sundfør K; Kristensen GB; Lyng H; Malinen E
    Int J Radiat Oncol Biol Phys; 2012 Mar; 82(3):e485-92. PubMed ID: 22014954
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dynamic contrast-enhanced MRI histogram parameters predict progression-free survival in patients with advanced esophageal squamous carcinoma receiving concurrent chemoradiotherapy.
    Xu L; Ge X; Sun N; Liu X
    Acta Radiol; 2020 Oct; 61(10):1316-1325. PubMed ID: 32053003
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DCE-MRI of patient-derived xenograft models of uterine cervix carcinoma: associations with parameters of the tumor microenvironment.
    Hauge A; Wegner CS; Gaustad JV; Simonsen TG; Andersen LMK; Rofstad EK
    J Transl Med; 2017 Nov; 15(1):225. PubMed ID: 29100521
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of liver fibrosis using pharmacokinetic parameters of dynamic contrast-enhanced magnetic resonance imaging.
    Li Z; Sun J; Chen L; Huang N; Hu P; Hu X; Han G; Zhou Y; Bai W; Niu T; Yang X
    J Magn Reson Imaging; 2016 Jul; 44(1):98-104. PubMed ID: 26707910
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlation of K
    Wang D; Liu S; Fu J; Zhang P; Zheng S; Qiu B; Liu H; Ye Y; Guo J; Zhou Y; Jiang H; Yin S; He H; Xie C; Liu H
    J Immunother Cancer; 2024 Jun; 12(6):. PubMed ID: 38910009
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cluster analysis of dynamic contrast enhanced MRI reveals tumor subregions related to locoregional relapse for cervical cancer patients.
    Torheim T; Groendahl AR; Andersen EK; Lyng H; Malinen E; Kvaal K; Futsaether CM
    Acta Oncol; 2016 Nov; 55(11):1294-1298. PubMed ID: 27564398
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dynamic contrast-enhanced magnetic resonance imaging as a predictor of outcome in head-and-neck squamous cell carcinoma patients with nodal metastases.
    Shukla-Dave A; Lee NY; Jansen JF; Thaler HT; Stambuk HE; Fury MG; Patel SG; Moreira AL; Sherman E; Karimi S; Wang Y; Kraus D; Shah JP; Pfister DG; Koutcher JA
    Int J Radiat Oncol Biol Phys; 2012 Apr; 82(5):1837-44. PubMed ID: 21601373
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DCE-MRI of the hypoxic fraction, radioresponsiveness, and metastatic propensity of cervical carcinoma xenografts.
    Ellingsen C; Hompland T; Galappathi K; Mathiesen B; Rofstad EK
    Radiother Oncol; 2014 Feb; 110(2):335-41. PubMed ID: 24231244
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peritumoral interstitial fluid flow velocity predicts survival in cervical carcinoma.
    Hompland T; Lund KV; Ellingsen C; Kristensen GB; Rofstad EK
    Radiother Oncol; 2014 Oct; 113(1):132-8. PubMed ID: 25443501
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dynamic contrast-enhanced 3-T MR imaging in cervical cancer before and after concurrent chemoradiotherapy.
    Kim JH; Kim CK; Park BK; Park SY; Huh SJ; Kim B
    Eur Radiol; 2012 Nov; 22(11):2533-9. PubMed ID: 22653283
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.